Darius Lakdawalla, PhD, director of research, Schaeffer Center for Health Policy & Economics at the University of Southern California, discusses the growing importance of value assessment in the US market, highlighting research gaps and the need for equitable access to prescription drugs, as a presenter at the ISPOR 2024 conference.
ISPOR—The Professional Society for Health Economics and Outcomes Research 2024 conference will take place this year in Atlanta, GA from March 5-8, to discuss the latest methodologies, data analytics, and evidence-based approaches that drive transformative changes in health and well-being.
Value-based benefit design is of upmost importance in the pharmaceutical industry, and there is also a need for potential for cost sharing policies to exacerbate existing inequalities in health care, says Darius Lakdawalla, PhD, director of research, Schaeffer Center for Health Policy & Economics, University of Southern California (USC). Lakdawalla will be attending ISPOR as a presenter.
Transcript
What are you looking forward to the most at this year’s ISPOR conference?
I think it's a pivotal time for pharmacoeconomics right now with the rising importance of value assessment in the US market and growing questions about how to demonstrate value and pay for value. So, I'm excited to see what developments the field has come to over the past year. I'm particularly interested in working towards strategies for bringing those research findings into the policy sphere to improve the way that we value drugs and pay for drugs.
What do you hope attendees take away from the conference and the session you are presenting on?
One of the most important issues that we'll be discussing in our session on cost sharing is the role of health insurance in mediating the allocation of prescription drugs and the value of prescription drugs. From that perspective, I think that there's been too much focus on patient cost sharing and not enough focus on getting value right, when determining what innovators should earn for their drugs.
Cost sharing has often been a tool for denying access to patients, frequently with deleterious impacts on their health. But instead, it should be used as a strategy for ensuring that the right drug is provided to the right patient at the right time.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More